Discover trends, market shifts, and competitive outlooks for the sarcopenia treatment industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Are the Projected Market Size and Growth Rates for the Sarcopenia Treatment Market From 2025 To 2029?

In recent times, the market size for treatment of sarcopenia has been experiencing remarkable growth. The market, which will be valued at $3.52 billion in 2024, is anticipated to escalate to $3.73 billion in 2025, expanding at a compound annual growth rate of 6.1%. The historic surge in market growth can be ascribed to factors like an increasing elderly population, enhanced awareness and diagnostic methods, shifts in lifestyle trends, initiatives for public health, and regulatory authorizations.

In the upcoming years, the market for sarcopenia treatment is anticipated to witness substantial growth. By 2029, it is predicted to reach a market value of $4.72 billion, expanding at a compound annual growth rate (CAGR) of 6.0%. The surge during the forecast period can be credited to factors such as personalized medicine, nutritional interventions, the advent of digital health platforms, patient knowledge and empowerment, and worldwide health initiatives. Key trends during this period encompass customized treatments, the introduction of fresh drug categories, the integration of digital health, collaborative research endeavors, and increased emphasis on research and development.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13926&type=smp

Which Factors and External Forces Are Driving Demand in the Sarcopenia Treatment Market?

The increase in malnutrition is predicted to drive the expansion of the sarcopenia treatment market in the future. Malnutrition entails the deficiencies, excesses, or imbalances in a person’s consumption of energy and nutrients. It encompasses both undernutrition and diet-related noncommunicable diseases such as overweight and obesity. Therapies for sarcopenia assist in addressing the overlapping conditions of malnutrition and sarcopenia in elderly individuals with interventions such as exercise and nutritional therapy. These aim to enhance muscle mass, strength, and general nutritional condition. For instance, a report released by the World Health Organization (WHO), a United Nations agency based in Switzerland, in December 2023 conveyed that malnutrition continues to be a major global health concern with around 462 million underweight individuals and 149 million children under five years of age suffering from stunting in 2022. Hence, the increase in malnutrition is fostering the growth of the sarcopenia treatment market.

Which Segments in the Sarcopenia Treatment Offer the Most Growth?

The sarcopenia treatment market covered in this report is segmented –

1) By Treatment Type: Protein Supplements, Vitamin B12 Supplements, Vitamin D And Calcium Supplements, Other Treatment Types

2) By Type: Primary Sarcopenia, Secondary Sarcopenia

3) By Route Of Administration: Oral, Parenteral, Enteral

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

Subsegments:

1) By Protein Supplements: Whey Protein, Casein Protein, Soy Protein, Plant-Based Protein

2) By Vitamin B12 Supplements: Cyanocobalamin, Methylcobalamin

3) By Vitamin D And Calcium Supplements: Vitamin D2, Vitamin D3, Calcium Carbonate, Calcium Citrate

4) By Other Treatment Types: Exercise Programs, Hormone Replacement Therapy, Other Nutritional Interventions

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=13926&type=smp

What Are the Fastest-Growing Geographies in the Sarcopenia Treatment Market?

North America was the largest region in the sarcopenia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sarcopenia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Cutting-Edge Market Trends Are Expected to Drive theSarcopenia Treatment Market’s Growth?

The sarcopenia treatment market is seeing a shift in focus by major companies towards the development of advanced clinical studies to identify superior treatment options. Clinical studies are systematic investigations involving human subjects to determine the safety and efficacy of medical interventions. In September 2023, for example, the France-based biotech firm, Biophytis, received authorization from the Food and Drug Administration (FDA) to initiate the SARA-31 Phase 3 study focused on sarcopenia. The goal is to analyse the effectiveness and safety of Sarconeos (BIO101) in treating patients with sarcopenia who are at risk of motor disability. This study represents a major step forward in technological and pharmaceutical treatment strategies, and could potentially provide efficacy and safety benefits for patients with severe sarcopenia. This is the first phase 3 study of its kind in sarcopenia to receive FDA authorization. The study will involve roughly 900 sarcopenia patients aged 65 and over, with low walking speed and reduced hand grip strength. Key outcomes of interest include the risk of major mobility disability (MMD), walking speed, hand grip strength, and patient-reported quality of life.

View the full report here:

https://www.thebusinessresearchcompany.com/report/sarcopenia-treatment-global-market-report

What Are the Key Elements That Define the Sarcopenia Treatment Market?

Sarcopenia treatment refers to medical interventions and lifestyle approaches designed to counteract age-related muscle loss and maintain or improve skeletal muscle mass and function. The treatment is aimed at mitigating age-related muscle loss, improving muscle strength, and enhancing overall physical function and mobility.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13926

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model